Power Transformation Toward a Linear Regression Quantile von Mu, Yunming, He, Xuming

Volltext

A Phase 1b, Open-Label Study of Eftozanermin Alfa in Combination with Bortezomib and Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma von Richardson, Paul G., Polepally, Akshanth R., Motwani, Monica, Mu, Yunming, Salman, Zeena, Penugonda, Sudhir, Moreau, Philippe

Volltext

AIDE: Adaptive intrapatient dose escalation designs to accelerate Phase I clinical trials von Zhou, Yanhong, Zhao, Yujie, Cicconetti, Greg, Mu, Yunming, Yuan, Ying, Wang, Li, Penugonda, Sudhir, Salman, Zeena

Volltext

A DYNAMIC QUANTILE REGRESSION TRANSFORMATION MODEL FOR LONGITUDINAL DATA von Mu, Yunming, Wei, Ying

Volltext

Direct targeting of RAS in pancreatic ductal adenocarcinoma with RMC-6236, a first-in-class, RAS-selective, orally bioavailable, tri-complex RAS MULTI (ON) inhibitor von Gustafson, W. Clay, Wildes, David, Rice, Meghan A., Lee, Bianca J., Jiang, Jingjing, Wang, Zhengping, Chang, Stephanie, Flagella, Mike, Mu, Yunming, Dinglasan, Nuntana, Nasholm, Nicole, Evans, James W., Seamon, Kyle, Cregg, Jim, Bermingham, Alun, Freilich, Rebecca, Gill, Adrian L., Koltun, Elena, Smith, Jacqueline A, Singh, Mallika

Volltext

Clinical and Economic Burden of Commercially Insured Patients with Acromegaly in the United States: A Retrospective Analysis von Placzek, Hilary, Xu, Yaping, Mu, Yunming, Begelman, Susan M., Fisher, Maxine

Volltext

Dietary management and major clinical events in patients with long-chain fatty acid oxidation disorders enrolled in a phase 2 triheptanoin study von Vockley, Jerry, Longo, Nicola, Madden, Megan, Dwyer, Lauren, Mu, Yunming, Chen, Chao-Yin, Cataldo, Jason

Volltext

TRENDS IN CONVENTIONAL AND EMERGING CARDIOVASCULAR RISK FACTORS AMONG U.S. ADULTS WITH TYPE II DIABETES OR PRE-DIABETES: THE NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY 1999-2... von Mu, Yunming, Xu, Yaping, Calingaert, Brian, Kolatkar, Nik

Volltext

Dietary management and major clinical events in patients with longchain fatty acid oxidation disorders enrolled in a phase 2 triheptanoin study von Vockley, Jerry, Longo, Nicola, Madden, Megan, Dwyer, Lauren, Mu, Yunming, Chen, Chao-Yin, Cataldo, Jason

Volltext

Surgical Experience in Two Multicenter, Open-Label Phase 3 Studies of Emicizumab in Persons with Hemophilia A with Inhibitors (HAVEN 1 and HAVEN 2) von Kruse-Jarres, Rebecca, Callaghan, Michael U., Croteau, Stacy E., Jimenez-Yuste, Victor, Khoo, Liane, Liesner, Ri, Matsushita, Tadashi, Recht, Michael, Young, Guy, Chang, Tiffany, Dhalluin, Christophe, Mu, Yunming, Xu, Jin, Devenport, Jenny, Ko, Richard H., Solari, Paul, Oldenburg, Johannes

Volltext

Practical Confidence Intervals for Regression Quantiles von Kocherginsky, Masha, He, Xuming, Mu, Yunming

Volltext

AML-058: First-In-Human Study of a Trail Receptor Agonist Fusion Protein, Eftozanermin Alfa, in Patients with Relapsed/Refractory Acute Myeloid Leukemia and Diffuse Large B-Cell Ly... von Jongen-Lavrencic, Mojca, Yuda, Junichiro, Mous, Rogier, Olszewski, Adam, Nijland, Marcel, Abedin, Sameem, Calvo, Emiliano, Nuthalapati, Silpa, Motwani, Monica, Modi, Dimple, Mu, Yunming, Petrich, Adam M., Penugonda, Sudhir, Morillo, Daniel

Volltext

Abstract PR014: Preliminary safety and anti-tumor activity of RMC-6291, a first-in-class, tri-complex KRASG12C(ON) inhibitor, in patients with or without prior KRASG12C(OFF) inhibi... von Jänne, Pasi A., Bigot, Frédéric, Papadopoulos, Kyriakos, Eberst, Lauriane, Sommerhalder, David, Lebellec, Loic, Voon, Pei Jye, Pellini, Bruna, Kalinka, Ewa, Arbour, Kathryn, Herzberg, Benjamin, Boni, Valentina, Bordenave, Stephanie, Lee, Hyun Woo, Ou, Sai I., Riess, Jonathan Wesley, Beck, Joseph T., Ponz-Sarvise, Mariano, Ascierto, Paolo Antonio, Choi, Yoon Ji, Yang, Michelle, Bao, Lei, Raman, Rakesh, Yang, Luxi, Mu, Yunming, Wong, Sofia, Dua, Richa, Johnson, Melissa

Volltext

Abstract 526: RMC-9805, a first-in-class, mutant-selective, covalent and oral KRASG12D(ON) inhibitor that induces apoptosis and drives tumor regression in preclinical models of KRA... von Jiang, Lingyan, Menard, Marie, Weller, Caroline, Wang, Zhican, Burnett, Les, Aronchik, Ida, Steele, Shelby, Flagella, Mike, Zhao, Ruiping, Evans, James W W., Chin, Shook, Chou, Kang-Jye, Mu, Yunming, Longhi, Michael, McDowell, Laura, Knox, John E., Gill, Adrian, Smith, Jacqueline A., Singh, Mallika, Quintana, Elsa, Jiang, Jingjing

Volltext

Abstract TP72: The PRISMS Trial: Baseline Characteristics of the First 100 Subjects von Khatri, Pooja, Devlin, Thomas, Sapkota, Biggya, Sethi, Pramod, Mejilla, Jennifer, Lopez, J I, Jauch, Edward C, Broderick, Joseph, Chatterjee, Anjan, Levine, Steven, Romano, Jose G, Saver, Jeffrey I, Yeatts, Sharon, Mu, Yunming, Tayama, Darren

Volltext

Abstract 3597: Direct targeting of KRASG12X mutant cancers with RMC-6236, a first-in-class, RAS-selective, orally bioavailable, tri-complex RASMULTI(ON) inhibitor von Koltun, Elena S., Rice, Meghan A., Gustafson, W. Clay, Wilds, David, Jiang, Jingjing, Lee, Bianca J., Wang, Zhengping, Chang, Stephanie, Flagella, Mike, Mu, Yunming, Dinglasan, Nuntana, Nasholm, Nicole, Evans, James W., Wang, Yingyun, Seamon, Kyle, Liu, Yang, Blaj, Cristina, Knox, John, Freilich, Rebecca, Quintana, Elsa, Cregg, Jim, Bermingham, Alun, Gill, Adrian L., Smith, Jacqueline Am, Singh, Mallika

Volltext

Comparison of statistical and operational properties of subject randomization procedures for large multicenter clinical trial treating medical emergencies von Zhao, Wenle, Mu, Yunming, Tayama, Darren, Yeatts, Sharon D

Volltext

Acceptable Safety of Bevacizumab Therapy in Patients with Brain Metastases as a Result of Non—Small-Cell Lung Cancer von Akerley, Wallace, Langer, Corey, Oh, Yun, Strickland, D.K, Kolb, Margaret, Xia, Qi, Mu, Yunming, Huang, Jane, Socinski, Mark

Volltext

Deicing system and deicing method for front edge of aircraft airfoil von ZHENG YING, REN WEIGUO, ZHANG FENG, LIU XIANLONG, MU YUNMING, GUO JIE

Volltext bestellen

Wind tunnel test propeller blade angle adjusting device and adjusting method von ZHENG YING, XU QIAN, REN WEIGUO, ZHANG FENG, LIU XIANLONG, MU YUNMING

Volltext bestellen